Alleviating cancer drug toxicity by inhibiting a bacterial enzyme.
Alleviating cancer drug toxicity by inhibiting a bacterial enzyme.
复制标题
DOI:
10.1126/science.1191175
复制
发表时间:
2010-11-05
期刊:
影响因子:
--
通讯作者:
Redinbo MR
中科院分区:
文献类型:
--
作者:
Wallace BD;Wang H;Lane KT;Scott JE;Orans J;Koo JS;Venkatesh M;Jobin C;Yeh LA;Mani S;Redinbo MR
The dose-limiting side effect of the common colon cancer chemotherapeutic CPT-11 is severe diarrhea caused by symbiotic bacterial β-glucuronidases that reactivate the drug in the gut. We sought to target these enzymes without killing the commensal bacteria essential for human health. Potent bacterial β-glucuronidase inhibitors were identified by high-throughput screening and shown to have no effect on the orthologous mammalian enzyme. Crystal structures established that selectivity was based on a loop unique to bacterial β-glucuronidases. Inhibitors were highly effective against the enzyme target in living aerobic and anaerobic bacteria, but did not kill the bacteria or harm mammalian cells. Finally, oral administration of an inhibitor protected mice from CPT-11–induced toxicity. Thus, drugs may be designed to inhibit undesirable enzyme activities in essential microbial symbiotes to enhance chemotherapeutic efficacy.
登录
查看更多内容
影响因子:
14.9
作者:
Marchler-Bauer A;Anderson JB;Chitsaz F;Derbyshire MK;DeWeese-Scott C;Fong JH;Geer LY;Geer RC;Gonzales NR;Gwadz M;He S;Hurwitz DI;Jackson JD;Ke Z;Lanczycki CJ;Liebert CA;Liu C;Lu F;Lu S;Marchler GH;Mullokandov M;Song JS;Tasneem A;Thanki N;Yamashita RA;Zhang D;Zhang N;Bryant SH
通讯作者:
Bryant SH
影响因子:
64.8
作者:
JACOBSON, RH;ZHANG, XJ;MATTHEWS, BW
通讯作者:
MATTHEWS, BW
影响因子:
3
作者:
Kurita, Akinobu;Kado, Shoichi;Yokokura, Teruo
通讯作者:
Yokokura, Teruo
影响因子:
2.6
作者:
GRILL, JP;MANGINOTDURR, C;BALLONGUE, J
通讯作者:
BALLONGUE, J
影响因子:
6.8
作者:
Redinbo, Matthew R.;Champoux, James J.;Hol, Wim G.J.
通讯作者:
Hol, Wim G.J.